DPYSL3 and cancer: Univariate analysis for overall survival (OS) showed that tumour multiplicity (multiple), serosal invasion, portal vein invasion, hepatic vein invasion, T3-4 cancer [UICC stage (8th)], history of T2D and PM of DPYSL3 were the significant risk factors for reduced survival (Supplemental Table S2).